Publications
- HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.2009 | First Faculty of Medicine
- Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates2009 | First Faculty of Medicine
- HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity2009 | First Faculty of Medicine
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting2008 | First Faculty of Medicine
- Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting2008 | First Faculty of Medicine
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity2005 | First Faculty of Medicine
- Polymer carriers for targeted drug delivery and controlled drug release2003 | First Faculty of Medicine
- HPMA copolymers, drug carriers, doxorubicin, drug targeting, drug delivery, cytotoxicity2003 | First Faculty of Medicine
- Starlike vs. classic macromolecular prodrugs: Two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs2003 | First Faculty of Medicine
- Antibody-targeted HPMA copolymer-bound anthracycline antibiotics2003 | First Faculty of Medicine
Loading network view...